World
Pancreatic cancer drug Daraxonrasib gets approval fromFDA: All you need to know
FDA officials gave expedited approval to daraxonrasib, which blocks a mutated protein that fuels tumor growth
Read full story on Hindustan Times →
World — Hindustan Times

